Boyuan New Materials (301617)
Overview
Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sale of fine chemicals in China. It operates in four segments: Iodine Derivatives, Industrial Catalysts (precious metals), Organosilicon Series, and Chemiluminescent Materials. The company offers iodine derivatives, such as potassium iodide, sodium iodide, potassium iodate, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexameth
Employees748
Market Cap$9.1B
Revenue$1.5B
Listed OnShenzhen Stock Exchange
Ticker301617
CEOMr. Guoqing Yu
HeadquartersShouguang